Sandwich-like neoadjuvant therapy with bevacizumab for locally advanced rectal cancer: a phase II trial

被引：0
|
作者：
Jian Xiao
Zexian Chen
Wenyun Li
Zuli Yang
Yan Huang
Jian Zheng
Yanhong Deng
Lei Wang
Donglin Ren
Junsheng Peng
Ping Lan
Jianping Wang
机构：
[1] Sun Yat-sen University,Department of Medical Oncology, The Sixth Affiliated Hospital
[2] Sun Yat-sen University,Department of Colorectal Surgery, The Sixth Affiliated Hospital
[3] National University of Singapore,Centre for Quantitative Medicine, Duke
[4] Sun Yat-sen University,NUS Graduate Medical School
[5] Sun Yat-sen University,Department of Pathology, The Sixth Affiliated Hospital
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 76卷
关键词：
Neoadjuvant therapy; Bevacizumab; Locally advanced rectal cancer; Safety; Efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：21 / 27
页数：6
相关论文
共 50 条
  • [1] Sandwich-like neoadjuvant therapy with bevacizumab for locally advanced rectal cancer: a phase II trial
    Xiao, Jian
    Chen, Zexian
    Li, Wenyun
    Yang, Zuli
    Huang, Yan
    Zheng, Jian
    Deng, Yanhong
    Wang, Lei
    Ren, Donglin
    Peng, Junsheng
    Lan, Ping
    Wang, Jianping
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (01) : 21 - 27
  • [2] PHASE II TRIAL OF NEOADJUVANT BEVACIZUMAB, CAPECITABINE, AND RADIOTHERAPY FOR LOCALLY ADVANCED RECTAL CANCER
    Crane, Christopher H.
    Eng, Cathy
    Feig, Barry W.
    Das, Prajnan
    Skibber, John M.
    Chang, George J.
    Wolff, Robert A.
    Krishnan, Sunil
    Hamilton, Stanley
    Janjan, Nora A.
    Maru, Dipen M.
    Ellis, Lee M.
    Rodriguez-Bigas, Miguel A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03): : 824 - 830
  • [3] Phase II Trial of Neoadjuvant Chemotherapy with XELOX plus Bevacizumab for Locally Advanced Rectal Cancer
    Uehara, Keisuke
    Ishiguro, Seiji
    Sakamoto, Eiji
    Maeda, Atsuyuki
    Inoue, Masaya
    Tojima, Yuichiro
    Kobayashi, Satoshi
    Omiya, Naoki
    Ishizuka, Naoki
    Nakao, Akimasa
    Goto, Hidemi
    Nagino, Masato
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (08) : 1041 - 1044
  • [4] Intensified Total Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer: A Phase II Trial
    De Felice, F.
    D'Ambrosio, G.
    Iafrate, F.
    Gelibter, A.
    Magliocca, F. M.
    Musio, D.
    Caponetto, S.
    Casella, G.
    Clementi, I
    Picchetto, A.
    Sirgiovani, G.
    Parisi, M.
    Orciuoli, C.
    Torrese, G.
    De Toma, G.
    Tombolini, V
    Cortesi, E.
    CLINICAL ONCOLOGY, 2021, 33 (12) : 788 - 794
  • [5] Phase II trial of neoadjuvant bevacizumab (BEV), capecitabine (CAP), and radiotherapy (XRT) for locally advanced rectal cancer
    Crane, C. H.
    Eng, C.
    Feig, B. W.
    Das, P.
    Skibber, J. M.
    Chang, G. J.
    Wolff, R. A.
    Krishnan, S.
    Maru, D. M.
    Ellis, L. M.
    Rodriguez-Bigas, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Neoadjuvant bevacizumab, capecitabine, and radiotherapy in locally advanced rectal cancer: Interim results of a phase II CRAB trial.
    Velenik, V.
    Ocvirk, J.
    Omejc, M.
    Music, M.
    Anderluh, F.
    Oblak, I.
    Edhemovic, I.
    Bracelj, E.
    Kropivnik, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] BEVACIZUMAB IN PREOPERATIVE TREATMENT OF LOCALLY ADVANCED RECTAL CANCER -CRAB PHASE II TRIAL
    Velenik, Vaneja
    Ocvirk, Janja
    Music, Maja
    Bracko, Matej
    Anderluh, Franc
    Oblak, Irena
    Edhemovic, Ibrahim
    Brecelj, Erik
    Kropivnik, Mateja
    Omejc, Mirko
    ANNALS OF ONCOLOGY, 2011, 22 : v130 - v130
  • [8] A Phase II Trial of Neoadjuvant Capecitabine Combined With Hyperfractionated Accelerated Radiation Therapy in Locally Advanced Rectal Cancer
    Marsh, Robert de W.
    George, Thomas J.
    Siddiqui, Tariq
    Mendenhall, William M.
    Zlotecki, Robert A.
    Grobmyer, Stephen
    Hochwald, Steven
    Chang, Myron
    Larson, Bradley
    King, Judy
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (03): : 251 - 256
  • [9] Long term efficacy results from the phase II CRAB trial: Neoadjuvant bevacizumab, capecitabine and radiotherapy in locally advanced rectal cancer
    Velenik, V.
    Omejc, M.
    Ocvirk, J.
    Edhemovic, I.
    Anderluh, F.
    Oblak, I.
    But-Hadzic, J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [10] A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
    Giampietro Gasparini
    Francesco Torino
    Takayuki Ueno
    Stefano Cascinu
    Teresa Troiani
    Alberto Ballestrero
    Rossana Berardi
    Junichi Shishido
    Akihiko Yoshizawa
    Yukiko Mori
    Satoshi Nagayama
    Paola Morosini
    Masakazu Toi
    Angiogenesis, 2012, 15 : 141 - 150
12345